Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShanghai Jiao Tong University School of Medicine

About this trial

The objectives of this multicenter, prospective, observational study were to investigate the incidence of dyspeptic symptoms in patients with Helicobacter pylori (H. pylori) infection and to continuously follow up the remission of dyspeptic symptoms after H. pylori eradication, so as to provide reference for the clinical diagnosis and treatment strategies of patients with H. pylori infection and dyspeptic symptoms.

Eligibility criteria

Qualifiers

Male or female patients aged 18-80 years

H. pylori infection diagnosed by 13C/ 14C-UBT (> 2 times the cutoff value) and/or gastroscopy (rapid urease strong positive and histological positive)

Treatment-naive patients with Helicobacter pylori

Ability and willingness to participate in the study and to sign and give informed consent

Disqualifiers

Under 18 or over 80 years old

Organic digestive diseases, such as active peptic ulcer, gastroesophageal reflux, gastrointestinal bleeding, acute/chronic pancreatitis, acute/chronic cholecystitis, gallstones, intestinal obstruction, inflammatory bowel disease, etc.

Combined with melena, hematemesis, anemia, emaciation and other alarm symptoms

Pregnant and lactating women

Trial design

Treatments tested in this trial

  • Epidemiological questionnaire and Functional Dyspepsia Symptom Diary(FDSD)

Treatment groups

2,242 Participants
are divided into 1 treatment group

Sponsors and collaborators